# U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

> **NCT07325578** · NA · RECRUITING · sponsor: **Precision IO Group** · enrollment: 60 (estimated)

## Conditions studied

- Bone Tumor
- Osteoporosis
- Traumatic Fracture

## Interventions

- **DEVICE:** Percutaneous procedure in the MSK structures of the pelvis and/or the spine

## Key facts

- **NCT ID:** NCT07325578
- **Lead sponsor:** Precision IO Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-28
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07325578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07325578, "U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07325578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*